Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Catriona Jamieson
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Catriona Jamieson
Dr. Jamieson specialized in myeloproliferative disorders (MPDs) and leukemia. Myeloproliferative neoplasms are a family of uncommon but not rare degenerative disorders in which the body overproduces blood cells.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Constellation Pharmaceuticals
- ID
- NCT04603495
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 400 study participants
- Last Updated